125 related articles for article (PubMed ID: 16920483)
1. MD-2.
Visintin A; Iliev DB; Monks BG; Halmen KA; Golenbock DT
Immunobiology; 2006; 211(6-8):437-47. PubMed ID: 16920483
[TBL] [Abstract][Full Text] [Related]
2. Innate recognition of lipopolysaccharide by Toll-like receptor 4/MD-2 and RP105/MD-1.
Miyake K; Ogata H; Nagai Y; Akashi S; Kimoto M
J Endotoxin Res; 2000; 6(5):389-91. PubMed ID: 11521060
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
[TBL] [Abstract][Full Text] [Related]
4. Myeloid differentiation 2 as a therapeutic target of inflammatory disorders.
Park SH; Kim ND; Jung JK; Lee CK; Han SB; Kim Y
Pharmacol Ther; 2012 Mar; 133(3):291-8. PubMed ID: 22119168
[TBL] [Abstract][Full Text] [Related]
5. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
Sauter KS; Brcic M; Franchini M; Jungi TW
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
[TBL] [Abstract][Full Text] [Related]
6. The Toll-like receptor 4 region Glu24-Pro34 is critical for interaction with MD-2.
Nishitani C; Mitsuzawa H; Hyakushima N; Sano H; Matsushima N; Kuroki Y
Biochem Biophys Res Commun; 2005 Mar; 328(2):586-90. PubMed ID: 15694388
[TBL] [Abstract][Full Text] [Related]
7. Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering.
Kobayashi M; Saitoh S; Tanimura N; Takahashi K; Kawasaki K; Nishijima M; Fujimoto Y; Fukase K; Akashi-Takamura S; Miyake K
J Immunol; 2006 May; 176(10):6211-8. PubMed ID: 16670331
[TBL] [Abstract][Full Text] [Related]
8. The lipopolysaccharide-recognition mechanism in cells expressing TLR4 and CD14 but lacking MD-2.
Ohnishi T; Muroi M; Tanamoto K
FEMS Immunol Med Microbiol; 2007 Oct; 51(1):84-91. PubMed ID: 17614960
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists.
Peri F; Piazza M
Biotechnol Adv; 2012; 30(1):251-60. PubMed ID: 21664961
[TBL] [Abstract][Full Text] [Related]
10. Myeloid differentiation protein 2 silencing decreases LPS-induced cytokine production and TLR4/MyD88 pathway activity in alveolar macrophages.
Ren W; Hu L; Hua F; Jin J; Wang Y; Zhu L
Immunol Lett; 2011 Dec; 141(1):94-101. PubMed ID: 21849156
[TBL] [Abstract][Full Text] [Related]
11. Identification of LPS-binding peptide fragment of MD-2, a toll-receptor accessory protein.
Mancek M; Pristovsek P; Jerala R
Biochem Biophys Res Commun; 2002 Apr; 292(4):880-5. PubMed ID: 11944896
[TBL] [Abstract][Full Text] [Related]
12. [TLR4/MD -2-dependent recognition of H. pylori LPS during gastric inflammation].
Ishihara S; Kinoshita Y
Nihon Rinsho; 2005 Nov; 63 Suppl 11():69-74. PubMed ID: 16363507
[No Abstract] [Full Text] [Related]
13. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner.
Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K
J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925
[TBL] [Abstract][Full Text] [Related]
14. Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.
Mattis DM; Chervin AS; Ranoa DR; Kelley SL; Tapping RI; Kranz DM
Mol Immunol; 2015 Dec; 68(2 Pt A):203-12. PubMed ID: 26320630
[TBL] [Abstract][Full Text] [Related]
15. [The role of myeloid differential protein-2 in innate immunity].
Xu FL; Li L
Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):139-42. PubMed ID: 15285420
[TBL] [Abstract][Full Text] [Related]
16. Mechanism regulating cell surface expression and activation of Toll-like receptor 4.
Saitoh S; Miyake K
Chem Rec; 2006; 6(6):311-9. PubMed ID: 17304555
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the lipopolysaccharide receptor complex (CD14, TLR4, MD-2) and toll-like receptor 2 in systemic inflammatory response syndrome-positive patients with and without infection: relationship to tolerance.
Calvano JE; Agnese DM; Um JY; Goshima M; Singhal R; Coyle SM; Reddell MT; Kumar A; Calvano SE; Lowry SF
Shock; 2003 Nov; 20(5):415-9. PubMed ID: 14560104
[TBL] [Abstract][Full Text] [Related]
18. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
[TBL] [Abstract][Full Text] [Related]
19. [Functional roles of TLR4/MD-2 and RP105/MD-1 in innate recognition of LPS].
Kusumoto Y; Miyake K
Tanpakushitsu Kakusan Koso; 2002 Dec; 47(16 Suppl):2103-8. PubMed ID: 12518421
[No Abstract] [Full Text] [Related]
20. Cetacean Toll-like receptor 4 and myeloid differentiation factor 2, and possible cetacean-specific responses against Gram-negative bacteria.
Shishido R; Ohishi K; Suzuki R; Takishita K; Ohtsu D; Okutsu K; Tokutake K; Katsumata E; Bando T; Fujise Y; Murayama T; Maruyama T
Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e89-98. PubMed ID: 20434218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
